HealthCentral Hirva Mamdani, M.D. , medical oncologist and leader of the Thoracic Oncology Multidisciplinary Team at Karmanos, explained how immunotherapy works when treating non-small cell lung cancer, who is usually a candidate for this treatment, and how this infusion therapy differs from chemotherapy. Read the article here .
Detroit Free Press A Karmanos lung cancer survivor who smoked for over 30 years shares his journey of diagnosis and treatment with the Detroit Free Press. David Sternberg, M.D. , cardiothoracic surgeon and member of the Thoracic Oncology Multidisciplinary Team (MDT) at Karmanos, treated the survivor and explained why finding the disease early is important. Hirva Mamdani, M.D. , medical oncologist, leader of the Thoracic Oncology MDT and the director of the Lung Cancer Scree...
Already one of the most common forms of cancer, lung cancer is also the leading cause of cancer death. “Early detection of lung cancer plays a crucial role in improving survival rate from this deadly disease,” explained Hirva Mamdani, M.D. , medical oncologist, leader of the Thoracic Oncology Multidisciplinary Team and the director of the Lung Cancer Screening Program at the Barbara Ann Karmanos Cancer Institute. “We can save thousands of lives by encouraging our friends and family who are at high risk ...